| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 07/24/2003 | WO2003059898A2 Eponemycin and epoxomicin analogs and uses thereof |
| 07/24/2003 | WO2003059875A2 DERIVATIVES OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXY-CARBOXYLIC ACIDS USEFUL FOR THE TREATMENT OF DISEASES RESPONDING TO PPARα ACTIVATION |
| 07/24/2003 | WO2003059865A1 Processes for the preparation of glutamic acid compounds and intermediates thereof and novel intermediates used in the processes |
| 07/24/2003 | WO2003059864A2 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 07/24/2003 | WO2003059807A2 Crystalline solids of carvedilol and processes for their preparation |
| 07/24/2003 | US20030139630 Organic compound in liquid or dissolved form is mixed with formylation reagent in liquid or dissolved form in microreactor; efficiency, simplification |
| 07/24/2003 | US20030139628 Process for the preparation of optically active amines or salts thereof |
| 07/24/2003 | US20030139609 Aziridinyl quinone antitumor agents based on indoles and cyclopent[b]indoles |
| 07/24/2003 | US20030139605 Antiproliferative agents, treating or preventing osteoporosis, inflammation, and angiogenesis disorders, treating liver cancer |
| 07/24/2003 | US20030139475 Novel tricyclic compounds and drug compositions containing same |
| 07/24/2003 | US20030139464 Reduction of carbonyl compounds using the carbonyl reductase of kluyveromyces marxianus |
| 07/24/2003 | US20030139453 Difluorobutyric acid metalloprotease inhibitors |
| 07/24/2003 | US20030139449 Anxiolytic agents; psychological disorders; cognition activators |
| 07/24/2003 | US20030139424 Dietetic therapy |
| 07/24/2003 | US20030139404 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents |
| 07/24/2003 | US20030139388 Antiinflammatory agents; osteoporosis |
| 07/24/2003 | US20030139379 Autoimmune disease, osteoporosis, rheumatic diseases, skin disorders |
| 07/24/2003 | US20030139348 Animal growth regulators |
| 07/24/2003 | US20030138376 A compressed tablets comprising an embedded polymer matrix, insoluble and disintegrable in the solvents, removed by filtration, separation from a formed soluble product |
| 07/24/2003 | CA2472419A1 Coumarin derivatives, process for their production and use thereof |
| 07/24/2003 | CA2472377A1 Crystalline solids of carvedilol and processes for their preparation |
| 07/24/2003 | CA2472223A1 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to pparalpha activation |
| 07/24/2003 | CA2472209A1 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 07/23/2003 | EP1328550A2 Methods of selecting compounds for modulation of bladder function |
| 07/23/2003 | EP1328525A2 2,3,4,5-tetrahydro-1h-[1,4]diazepino[1,7-a]indole compounds |
| 07/23/2003 | EP1328515A1 Indoline derivatives and their use as 5-ht2 receptor ligands |
| 07/23/2003 | EP1328514A1 Amide derivatives as nmda receptor antagonists |
| 07/23/2003 | EP1328513A2 Diindolylmethane and c-substituted diindolylmethane compositions and methods for the treatment of multiple cancers |
| 07/23/2003 | EP1328510A2 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 07/23/2003 | EP0983274B1 Phthalocyanine and use of phthalocyanine as a marking agent |
| 07/23/2003 | EP0888278B1 Antidiabetic agents |
| 07/23/2003 | CN1431999A Indole derivatives with vascular damagine activity |
| 07/23/2003 | CN1431998A Growth hormone secretagogues |
| 07/23/2003 | CN1431997A 2-acyl indol derivatives and their use as anti-tumour agents |
| 07/23/2003 | CN1431996A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides |
| 07/23/2003 | CN1431901A S-methyl-dihydro-zipprasidone for treatment of psychiatric and ocular disorders |
| 07/23/2003 | CN1431197A Alanine class compound, its preparing method and use |
| 07/23/2003 | CN1115343C Process for prepn. of (1S,4R)-or (1R,4S)-4-(2-amino-6-chloro-9H-purin-9-yl) -2-cyclopentene-1-methanol |
| 07/23/2003 | CN1115330C N-(4-carbamimido-phenyl)-phenylglycinamid derivatives |
| 07/22/2003 | USRE38200 Indole-2,3-dione-3-oxime derivatives |
| 07/22/2003 | US6596877 Reaction with dimethyl carbonate using 4-(dimethylamino)pyridine, 1,4-diazabicyclo(2.2.2)octane, or 1,8-diazabicyclo(5.4.0)undec-7-ene basic catalyst |
| 07/22/2003 | US6596873 2-and 2,5-substituted phenylketoenols |
| 07/22/2003 | US6596772 Relates to trifluoromethyl sulfonyl and trifluoromethyl sulfonamido compounds and the physiologically acceptable salts and the prodrugs thereof. These compounds are expected to modulate the activity of protein tyrosine enzymes which are |
| 07/22/2003 | US6596753 Compounds of the indolecarboxylic family and use thereof |
| 07/22/2003 | US6596752 Inhibitors of α4β1 mediated cell adhesion |
| 07/22/2003 | US6596732 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same |
| 07/22/2003 | US6596522 Compositions and optical methods for determining transmembrane potentials across plasma membrane of biological cells |
| 07/22/2003 | US6596130 Using ionic liquids as solvents resulted in high yields with dramatically reduced reaction times |
| 07/22/2003 | CA2245250C Benzofuran-acrylic acid derivatives and their use as modulators of rxrs or rars receptors |
| 07/17/2003 | WO2003059014A1 Bis- and tris-(di)benzocarbazole-based materials as hole transport materials for organic light emitting devices |
| 07/17/2003 | WO2003057697A1 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, the preparation thereof and the application of same in therapeutics |
| 07/17/2003 | WO2003057670A2 Indoles as naaladase inhibitors |
| 07/17/2003 | WO2003057666A2 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057254A1 Preventives/remedies for urinary disturbance |
| 07/17/2003 | WO2003057212A1 Polyamide derivatives possessing antibacterial, antifungal or antitumor activity |
| 07/17/2003 | WO2003057169A2 4-dedimethylamino tetracycline compounds |
| 07/17/2003 | WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2002006280A3 INHIBITORS OF FACTOR Xa |
| 07/17/2003 | US20030135051 Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors |
| 07/17/2003 | US20030135049 Preparing camptothecin intermediates |
| 07/17/2003 | US20030134876 Inhibiting TNF alpha |
| 07/17/2003 | US20030134863 Preventives/remedies for alzheimer's disease |
| 07/17/2003 | US20030134827 Lactams or pharmaceutically acceptable salt forms thereof, wherein rings ring B is a 4-8 membered cyclic amide containing from 0-3 additional heteroatoms selected from N, O, and S, which are useful as metalloprotease inhibitors. |
| 07/17/2003 | US20030131425 Colorants |
| 07/17/2003 | CA2471760A1 Preventives/remedies for urinary disturbance |
| 07/17/2003 | CA2471204A1 Inhibitors of dipeptidyl peptidase iv |
| 07/16/2003 | EP1327636A2 Heterocyclic metallocenes and polymerisation catalysts |
| 07/16/2003 | EP1326993A2 PRODUCTION OF g(a)-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM |
| 07/16/2003 | EP1326867A2 Bridged piperazine derivatives |
| 07/16/2003 | EP1326842A1 Arylpiperazine derivatives and their use as psychotropic agents |
| 07/16/2003 | EP1326831A1 Substituted fused pyrroleimines and pyrazoleimines |
| 07/16/2003 | EP1326830A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
| 07/16/2003 | EP1326651A2 Dynamic organ function monitoring agents |
| 07/16/2003 | EP1326650A2 Hydrophilic light absorbing compositions for determination of physiological function in critically ill patients |
| 07/16/2003 | EP1326649A1 Tissue-specific exogenous optical agents |
| 07/16/2003 | EP1326648A1 Novel dyes for organ function monitoring |
| 07/16/2003 | EP1326623A1 Saururus chinensis extract for prevention and treatment of neurodegenerative disease |
| 07/16/2003 | EP1326602A1 Indole compounds as minimally physiologial function monitioring agents |
| 07/16/2003 | EP1326597A2 Methods for modulating bladder function |
| 07/16/2003 | EP1076558B1 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens |
| 07/16/2003 | CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 07/16/2003 | CN1430605A Process for synthesis of amine ethers from secondary amino oxides |
| 07/16/2003 | CN1430604A Process for preparation of indole derivatives and intermediates of the process |
| 07/16/2003 | CN1430603A Novel bicyclic compounds |
| 07/16/2003 | CN1114608C Novel camptothecine analogues, prepn. method therefor, use thereof, and pharmaceutical compositions contg. same |
| 07/15/2003 | US6593474 Adrenergic blocking agents |
| 07/15/2003 | US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
| 07/15/2003 | US6593322 Compounds and methods for modulation of estrogen receptors |
| 07/15/2003 | US6593312 Cyclic α-amino-γ-hydroxyamide compounds |
| 07/15/2003 | US6593148 Cyanine dye compounds and labeling methods |
| 07/15/2003 | US6592894 Hydrogel-isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/10/2003 | WO2003055884A1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 07/10/2003 | WO2003055848A2 Urea derivatives as vr1- antagonists |
| 07/10/2003 | WO2003055847A1 Carboxylic acid derivative |
| 07/10/2003 | WO2003055492A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 |
| 07/10/2003 | WO2003055484A1 Urea derivatives |
| 07/10/2003 | WO2003055478A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 07/10/2003 | WO2003032908A3 Novel prodrugs of n-h bond-containing compounds and methods of making thereof |
| 07/10/2003 | WO2003010140A3 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |